AAAAAA

   
Results: 1-7 |
Results: 7
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF FLUDARABINE AND CYTOSINE-ARABINOSIDE ADMINISTERED AS LOADING BOLUSES FOLLOWED BY CONTINUOUS INFUSIONS AFTER A PHASE I II STUDY IN PEDIATRIC-PATIENTS WITH RELAPSEDLEUKEMIAS/
Authors: AVRAMIS VI WIERSMA S KRAILO MD RAMILOTORNO LV SHARPE A WEN LM KWOCK R REAMAN GH SATO JK
Citation: Vi. Avramis et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF FLUDARABINE AND CYTOSINE-ARABINOSIDE ADMINISTERED AS LOADING BOLUSES FOLLOWED BY CONTINUOUS INFUSIONS AFTER A PHASE I II STUDY IN PEDIATRIC-PATIENTS WITH RELAPSEDLEUKEMIAS/, Clinical cancer research, 4(1), 1998, pp. 45-52
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF FLUDARABINE AND CYTOSINE-ARABINOSIDE ADMINISTERED AS LOADING BOLUSES FOLLOWED BY CONTINUOUS INFUSIONS AFTER A PHASE I II STUDY IN PEDIATRIC-PATIENTS WITH RELAPSEDLEUKEMIAS/
Authors: AVRAMIS VI WIERSMA S KRAILO MD RAMILOTORNO LV SHARPE A WEN LM KWOCK R REAMAN GH SATO JK
Citation: Vi. Avramis et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF FLUDARABINE AND CYTOSINE-ARABINOSIDE ADMINISTERED AS LOADING BOLUSES FOLLOWED BY CONTINUOUS INFUSIONS AFTER A PHASE I II STUDY IN PEDIATRIC-PATIENTS WITH RELAPSEDLEUKEMIAS/, Clinical cancer research, 4(1), 1998, pp. 45-52
INCREASED P21 WAF-1 AND P53 PROTEIN-LEVELS FOLLOWING SEQUENTIAL 3-DRUG-COMBINATION REGIMEN OF FLUDARABINE, CYTARABINE AND DOCETAXEL INDUCESAPOPTOSIS IN HUMAN LEUKEMIA-CELLS/
Authors: AVRAMIS VI NANDY P KWOCK R SOLORZANO MM MUKHERJEE SK DANENBERG P COHEN LJ
Citation: Vi. Avramis et al., INCREASED P21 WAF-1 AND P53 PROTEIN-LEVELS FOLLOWING SEQUENTIAL 3-DRUG-COMBINATION REGIMEN OF FLUDARABINE, CYTARABINE AND DOCETAXEL INDUCESAPOPTOSIS IN HUMAN LEUKEMIA-CELLS/, Anticancer research, 18(4A), 1998, pp. 2327-2338
TUMOR VOLUME AS A PREDICTOR OF LOCAL-CONTROL IN PATIENTS WITH LARYNGEAL CARCINOMA TREATED SURGICALLY
Authors: MUKHERJI SK WEISSLER MG SCHOCKLEY WW SCHELL MJ KWOCK R GERSTLE RJ
Citation: Sk. Mukherji et al., TUMOR VOLUME AS A PREDICTOR OF LOCAL-CONTROL IN PATIENTS WITH LARYNGEAL CARCINOMA TREATED SURGICALLY, Radiology, 209P, 1998, pp. 13-13
DEVELOPMENT OF ZIDOVUDINE (AZT) RESISTANCE IN JURKAT T-CELLS IS ASSOCIATED WITH DECREASED EXPRESSION OF THE THYMIDINE KINASE (TK) GENE AND HYPERMETHYLATION OF THE 5'-END OF HUMAN TK GENE
Authors: WU SJ LIU XP SOLORZANO MM KWOCK R AVRAMIS VI
Citation: Sj. Wu et al., DEVELOPMENT OF ZIDOVUDINE (AZT) RESISTANCE IN JURKAT T-CELLS IS ASSOCIATED WITH DECREASED EXPRESSION OF THE THYMIDINE KINASE (TK) GENE AND HYPERMETHYLATION OF THE 5'-END OF HUMAN TK GENE, Journal of acquired immune deficiency syndromes and human retrovirology, 8(1), 1995, pp. 1-9
HAMMERHEAD RIBOZYMES AS ANTIONCOGENE (N-MYC) BIOTHERAPEUTIC AGENTS
Authors: AVRAMIS VI LARSON GP SPEARS CP KWOCK R NELSON P MUTHLNL S ROSSL JJ
Citation: Vi. Avramis et al., HAMMERHEAD RIBOZYMES AS ANTIONCOGENE (N-MYC) BIOTHERAPEUTIC AGENTS, Clinical chemistry, 40(12), 1994, pp. 2336-2336
EVIDENCE OF IN-VITRO DEVELOPMENT OF DRUG-RESISTANCE TO AZIDOTHYMIDINEIN T-LYMPHOCYTIC LEUKEMIA-CELL LINES (JURKAT E6-1 AZT-100) AND IN PEDIATRIC-PATIENTS WITH HIV-1 INFECTION/
Authors: AVRAMIS VI KWOCK R SOLORZANO MM GOMPERTS E
Citation: Vi. Avramis et al., EVIDENCE OF IN-VITRO DEVELOPMENT OF DRUG-RESISTANCE TO AZIDOTHYMIDINEIN T-LYMPHOCYTIC LEUKEMIA-CELL LINES (JURKAT E6-1 AZT-100) AND IN PEDIATRIC-PATIENTS WITH HIV-1 INFECTION/, Journal of acquired immune deficiency syndromes, 6(12), 1993, pp. 1287-1296
Risultati: 1-7 |